Lauren Riker - Jan 2, 2024 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Senior Vice President, Finance
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jan 2, 2024
Transactions value $
-$5,088
Form type
4
Date filed
1/4/2024, 05:25 PM
Previous filing
Jul 7, 2023
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Tax liability -$5.09K -159 -0.7% $32.00 22.5K Jan 2, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.